ArticleJournal of gastrointestinal oncology2022

Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels.

Miao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.